Home > Insider Trading > Filing (0001181431-12-048181)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
820096	Perrigo Co	PRGO	Pharmaceutical Preparations (2834)	382799573

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1398276	Thomas Farrington	C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010	Senior Vp And Cio	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2012-08-29	3,000	$110.16	675	No	4	S	Direct
Common Stock	Acquisiton	2012-08-29	867	$30.06	1,542	No	4	M	Direct
Common Stock	Disposition	2012-08-29	867	$110.37	675	No	4	S	Direct
Common Stock	Acquisiton	2012-08-30	977	$20.50	1,652	No	4	M	Direct
Common Stock	Disposition	2012-08-30	977	$108.87	675	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option Right to Buy	Disposition	2012-08-29	867	$0.00	867	$30.06
Common Stock	Employee Stock Option Right to Buy	Disposition	2012-08-30	977	$0.00	977	$20.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2012-08-27	2019-08-25	No	4	M	Direct
978	2012-08-30	2017-08-30	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,098	Indirect	By 401(k) Plan

Footnotes

The price in column 4 is a weighted average. The prices actually received ranged from $110.13 to $110.18. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
The price in column 4 is a weighted average. The prices actually received ranged from $110.32 to $110.39. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
This transaction was effected pursuant to a Rule 10b5-1sales plan adopted by the reporting person on December 9, 2011. This 10b5-1 sales plan will expire on the close of business December 7, 2012.